<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dal-RÃ©</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Kesselheim</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Bourgeois</surname>
    <given-names>FT</given-names>
   </name>
  </person-group>
  <article-title>Increasing access to FDA Inspection reports on irregularities and misconduct in clinical trials</article-title>
  <source>J Am Med Assoc: JAMA</source>
  <year>2020</year>
  <volume>19</volume>
  <fpage>1903</fpage>
  <lpage>1904</lpage>
  <pub-id pub-id-type="doi">10.1001/jama.2020.1631</pub-id>
 </element-citation>
</ref>
